Anzeige
Mehr »
Donnerstag, 10.09.2026 - Börsentäglich über 12.000 News
Mehr als 4,5 Mrd. USD US-Staatsgeld für alte Bohrlöcher, diese Aktie räumt auf
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
10.09.26 | 13:19
5,630 Euro
+5,04 % +0,270
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
5,4105,57020:41
5,4405,54020:02

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiImplantica to host Capital Markets Day in Stockholm on September 910
25.08.Implantica to host Capital Markets Day in Stockholm on September 9438VADUZ, Liechtenstein, Aug. 25, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop...
► Artikel lesen
21.08.Implantica: Umsatz steigt um 66 % - FDA-Zulassung beflügelt Ausblick4
21.08.Implantica: Umsatz steigt um 66 % - FDA-Zulassung beflügelt US-Wachstumsaussichten7
21.08.Implantica AG Q2 Loss Declines4
21.08.Implantica publishes Interim Report January - June 2026 (Q2)510VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ -- FDA Approval of RefluxStop - Strategic Preparation Sets the Stage for Success Significant events in the second quarter of 2026RefluxStop...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
21.08.Implantica erhält FDA-Zulassung für Reflux-Implantat RefluxStop5
21.08.Implantica receives FDA approval for GERD implant RefluxStop3
21.08.Implantica receives FDA approval for RefluxStop - Opening the U.S. market595VADUZ, Liechtenstein, Aug. 21, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announced today that the U.S....
► Artikel lesen
14.08.Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST4
10.06.Implantica AG: Bulletin from the Annual General Meeting of Implantica AG216Today, June 10, 2026, the annual general meeting (the "AGM") of Implantica AG (publ) was held in Ruggell, Liechtenstein. The general meeting resolved to adopt all of the board of directors' resolution...
► Artikel lesen
09.06.Implantica announces launch of 20th RefluxStop Center of Excellence in Spain, part of a world-renowned US hospital group403VADUZ, Liechtenstein, June 9, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop...
► Artikel lesen
22.05.Implantica publishes Interim Report January - March 2026 (Q1)585VADUZ, Liechtenstein, May 22, 2026 /PRNewswire/ -- Substantially Advancing Clinical Outcomes & Economic Impact of RefluxStopSignificant events in the first quarter of 2026Secured over...
► Artikel lesen
21.05.Notice of Annual General Meeting of Implantica AG427VADUZ, Liechtenstein, May 21, 2026 /PRNewswire/ -- The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to...
► Artikel lesen
21.05.Implantica announces publication of a new health economics study showing RefluxStop's superior cost-effectiveness in the treatment of GERD in the Italian Healthcare System8
20.05.Implantica submits final response to FDA in the PMA application for RefluxStop for U.S. market approval1.213VADUZ, Liechtenstein, May 20, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including...
► Artikel lesen
19.05.Implantica announces new breakthrough long-term RefluxStop data on severe sufferers presented at DDW 2026938VADUZ, Liechtenstein, May 19, 2026 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop...
► Artikel lesen
19.05.IMPLANTICA: RefluxStop gains momentum at DDW 20262
18.05.Implantica presents the first quarter (Q1 2026) on May 22 at 15:00 CET328VADUZ, Liechtenstein, May 18, 2026 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the first quarter 2026 at 15:00 CET on May 22. The interim report for the first...
► Artikel lesen
06.05.Implantica publishes Annual Report 2025419VADUZ, Liechtenstein, May 6, 2026 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report...
► Artikel lesen
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1